text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 2H

text: Enitociclib

characteristic: treatment


status: PUBLIC

characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

tag: attribute

characteristic: age

text: FUNDACION JIMENEZ DIAZ (CLINICA DE LA CONCEPCION)

text: not applicable

text: not provided

text: not provided

text: not provided

text: patient samples taken post enitociclib treatment at different Cycles (C) and days of dosing (D) at different timepoints (as indicated in the title

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 4H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 6H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 8H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 4H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 0.5H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 1H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 2H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 6H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 8H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 Predose

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 Predose

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 0.5H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 1H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D2 24H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D3 48H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: FUNDACION JIMENEZ DIAZ (CLINICA DE LA CONCEPCION)

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D8 Predose

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: patient samples taken post enitociclib treatment at different Cycles (C) and days of dosing (D) at different timepoints (as indicated in the title

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D8 0.5H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D8 2H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 2H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 4H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 6H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 8H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 0.5H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 1H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 2H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 4H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 6H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 8H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 Predose

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 0.5H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: FUNDACION JIMENEZ DIAZ (CLINICA DE LA CONCEPCION)

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 1H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

text: patient samples taken post enitociclib treatment at different Cycles (C) and days of dosing (D) at different timepoints (as indicated in the title

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D8 Predose

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Human Whole Blood enitociclib treated-C1D8 0.5H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: Predose

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 Predose

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: Spain

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D3 24H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: Spain

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D3 48H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 2H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 4H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 6H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 8H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D2 24H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D8 2H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 0.5H

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 1H

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 2H

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 4H

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 6H

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: MAYO CLINIC - ROCHESTER

text: not applicable

text: not provided

text: not provided

text: not provided

text: patient samples taken post enitociclib treatment at different Cycles (C) and days of dosing (D) at different timepoints (as indicated in the title

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 8H

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D2_24Hr

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1_Predose

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1_2Hr

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15_Predose

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15_2Hr

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Sarah Cannon Research Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D16_24Hr

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Norton Healthcare

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1_4Hr

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1_6Hr

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1_8Hr

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15_6Hr

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15_4Hr

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: University of Cincinnati Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15_8Hr

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C2D1_Predose

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: John Theurer Cancer Center, Hackensack

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 Predose

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: John Theurer Cancer Center, Hackensack

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 2hr

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: John Theurer Cancer Center, Hackensack

text: not applicable

text: not provided

text: not provided

text: not provided

text: patient samples taken post enitociclib treatment at different Cycles (C) and days of dosing (D) at different timepoints (as indicated in the title

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D1 4hr

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: John Theurer Cancer Center, Hackensack

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: female

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 6hr

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: John Theurer Cancer Center, Hackensack

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: female

text: whole blood

text: Human Whole Blood enitociclib treated-C1D1 8hr

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D2 24hr

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Memorial Sloan Kettering Cancer Center

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C3D1 Predose

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Willamette Valley Cancer Institute

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C5D1 Predose

text: Enitociclib

characteristic: treatment


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 2hr

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D16 24hr

characteristic: title

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 6hr

text: Enitociclib

characteristic: treatment


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

characteristic: age

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

characteristic: description

text: not provided

text: not provided

characteristic: disease

text: not provided

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

text: Homo sapiens

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 4hr

text: Enitociclib


characteristic: External Id

text: Vincerx Pharma

characteristic: INSDC center name

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

characteristic: dosing timepoint

text: not applicable

characteristic: drug treatment and replicate

text: not provided

characteristic: ethnicity

text: USA

text: not provided

characteristic: isolate

text: not provided

text: Homo sapiens

characteristic: organism

text: not provided

text: not provided

text: not provided

text: not provided

text: male

text: whole blood

characteristic: tissue

text: Human Whole Blood enitociclib treated-C1D15 8hr

characteristic: title

text: Enitociclib


text: Vincerx Pharma

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: Highlands Oncology Group

text: not applicable

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided

text: Predose

text: not applicable

text: not provided

text: USA

text: not provided

text: not provided

characteristic: karyotype

text: Homo sapiens

text: not provided

characteristic: phenotype

text: not provided

characteristic: population

text: not provided

characteristic: race

text: not provided

text: male

characteristic: sex

text: whole blood

text: Human Whole Blood enitociclib treated-C1D15 Predose

text: Enitociclib

characteristic: treatment